Atrial Natriuretic Factor,Renal Failure and Hemodialysis

de Bold A.J. , de Bold M.L. , Sarda I.R. Functional-morphological studies on in vitro cardionatrin release. J Hypertens 1986; 4(Suppl 2): S3–7.

Rodeheffer R.J. , Tanaka I. , Imada T. , Hollister A.S. , Robertson D. , Inagami T. Atrial pressure and secretion of atrial natriuretic factor into the human circulation. J Am Coll Cardiol 1986; 8: 18–26.

Weidmann P. , Hasler L. , Gnaedinger M. Blood levels and renal effects of atrial natriuretic peptide in normal man. J Clin Invest 1986; 77: 734–42.

Espiner E. , Nichols M. , Yandle T. Studies on the secretion metabolism and action of natriuretic peptide in man. J Hypertens 1986; 4 suppl 2: S856–91.

Weidmann P. , Hellmueller B. , Uehlinger D. Plasma levels and cardiovascular, endocrine and excretory effects of atrial natriuretic peptide during different sodium intakes in man. J Clin Endocr Metab 1986; 62: 1027–36.

Needleman P. , Greenwald J.E. Atriopeptin: a cardiac hormone intimately involved in fluid, electrolyte and blood-pressure homeostasis. New Engl J Med 1986; 314: 828–34.

Weidmann P. , Saxenhofer H. , Ferrier C. , Shaw S.G. Atrial natriuretic peptide in man. Am J Nephrol 1988; 8: 1–14.

Morrissey E. , Wilner K. , Barager R. , Ward D. , Ziegler M. Atrial natriuretic factor in renal failure and posthemodialytic postural hypotension. Am J Kidney diseases XII 1988; 6: 510–5.

Saxenhofer H. , Gnaedinger M. , Weidmann P. Plasma levels and dialysance of atrial natriuretic peptide in terminal renal failure. Kidney Int 1987; 32: 554–61.

Rascher W. , Bald M. , Kroner F. , Tulassay D. , Muller-Wiefel D. Klinische Wertigkeit der messung des atrialen natriuretischen peptids im plasma von kindern mit chronischer niereinsufficienz. Zeitschrift fur Kardiologie 1988; 77: 61–4.

Cannella G. , Albertini A. , Assanelli D. Effects of changes in intravascular volume on atrial size and plasma levels of immunoreactive atrial natriuretic peptide in uremic man. Clinical Nephrology 1988; 30: 187–92.

Zoccali C. , Ciccarelli M. , Mallamaci F. Effect of ultrafiltration on plasma concentrations of atrial natriuretic peptide in hemodialysis patients. Nephrol Dial Transplant 1986; 1: 188–91.

Ando R. , Matsuda O. , Miyake S. , Yoshiyama N. Plasma levels of human atrial natriuretic factor in patients treated by hemodialysis and continuous ambulatory peritoneal dialysis. Nephron 1988; 50: 225–8.

Rauch W. , Hund E. , Sohl G. , Rascher W. , Mehls O. , Scharer K. Vasoactive hormones in children with chronic renal failure. Kidney Int 1983; 24 suppl 15: S27–333.

Shenker Y. , Port F. , Swartz R. , Gross M. , Grekin R. Atrial natriuretic hormone secretion in patients with renal failure. Life Sciences 1987; 41: 1635–44.

Larochelle P. , Beroniade V. , Gutkowska J. Influence of hemodialysis on the plasma levels of atrial natriuretic factor in chronic renal failure. Clin Invest Med 1987; 10: 350–4.

Peterson J. , Li C. , Bishop-Abney N. , Seniw C. Hemodynamic and atrial natriuretic peptide responses to fluid removal and re-infusion in hemodialysis patients. ASAIO Transactions 1988; 34: 509–11.

Talartschik J. , Eisenhauer T. , Voth E. , Sold G. , Scheler F. Ist der plasma-ANP-Spiegel ein index fur die volumenexpansion bei dialysepatienten? Zeitschrift fur Kardiologie 1988; 77: 72–7.

Eisenhauer T. , Talartschik J. , Scheler F. Detection of fluid overload by plasma concentration of human atrial natriuretic peptide in patients with renal failure. Klin Wochenschrift 1986; 64: 68–72.

Cannella G. , Rodella A. , Brunori G. , Gaggiotti M. , Sandrini M. , Maiorca R. Plasma concentrations of atrial natriuretic peptide in relation to body fluid status in chronic uremia. Nephrol Dial Transplant 1987; 2: 58–60.

Yamamoto Y. , Higa T. , Kitamura K. , Tanaka K. , Kangawa K. , Matsuo H. Plasma concentration of human atrial natriuretic polypeptide in patients with impaired renal function. Clinical Nephrology 1987; 27: 84–6.

Yamamoto Y. , Higa T. , Kitamura K. , Tanaka K. , Kangawa K. , Matsuo H. Plasma concentration of atrial natriuretic polypeptide in chronic hemodialysis patients. Regul Pept Suppl 1985; 4: 110–2.

Ogawa K. , Smith I. , Hodsman P. , Jackson B. , Woodcock E. , Johnstone C. Plasma atrial natriuretic peptide: concentrations and circulating forms in normal man and patients with chronic renal failure. Clinical and Experimental Pharmacology 1987; 14: 95–102.

Kojima S. , Inoue I. , Hirata Y. Plasma concentrations of immunoreactive atrial natriuretic polypeptide in patients on hemodialysis. Nephron 1987; 46: 45–8.

Burnier M. , Porchet M. , Waeber B. , Wauters J. , Brunner H. Effect du facteur natriuretique auriculaire sur I'hematocrite de patients en hemodialyse chronique. Schweiz Med Wschr 1987; 117: 1953–6.

Wilkins M. , Wood J. , Adu D. , Lote C. , Kendall M. , Michael J. Change in plasma immunoreactive atrial natriuretic peptide during sequential ultrafiltration and hemodialysis. Clinical Science 1986; 71: 157–60.

Anderson J. , Raine A. , Proudler A. , Bloom S. Effect of hemodialysis on plasma concentrations of atrial natriuretic peptide in adult patients with chronic renal failure. J Endocrinol 1986; 110: 193–6.

Shaw S.G. , Weidmann P. Potential pitfalls in the radioimmunoassay of physiological plasma levels of atrial natriuretic peptide. Z Kardiol 1988; 77 Suppl 2: 26–30.

Van Stone J.C. , Bauer J. , Garey J. The effect of dialysate sodium concentration on body fluid distribution during hemodialysis. Trans Am Soc Artif Internal Organs 1980; 26: 383–6.

Haller B. , Zuest H. , Shaw S. , Ghaedinger M. , Uehlinger D. , Weidmann P. Effects of posture and ageing on circulating atrial natriuretic peptide levels in man. J Hypertens 1987; 5: 551–6.

Ohashi M. , Fujio N. , Nawata H. High plasma concentrations of human atrial natriuretic polypeptide in aged men. J Clin End Metab 1987; 64: 81–5.

Bates E. , Shenker J. , Grekin R. Relationship between plasma levels of immunoreactive atrial natriuretic hormone and hemodynamic function in man. Circulation 1986; 73: 1155–61.

Sato F. , Kamoi K. , Wakiya Y. Relationship between plasma atrial natriuretic peptide levels and atrial pressure in man. J Clin Endocrinol Metab 1986; 63: 823–7.

Jahn H. , Schohn D. , Schmitt R. Hemodynamic studies in chronic terminal renal insufficiency. Effects of hemodialysis, hemofiltration and ultrafiltration procedures. Nephrologie 1981; 2: 53–62.

Kurokawa S. , Katoh Y. , Sugiyama T. Correlation of decreased plasma atrial natriuretic peptide level with left atrial diameter in chronic hemodialysis. Am J Cardiol 1987; 60: 1135.

Talartschick J. , Eisenhauer T. , Schilling H. , Zuchner C. , Scheeler F. Changes in atrial natriuretic factor after ultrafiltration as a parameter for differential diagnosis of fluid overload or cardiac disease, Proc Ann Meeting German Soc Nephrol Frankfurt 1986.

Gnaedinger M. , Lang R. , Hasler L. , Uehlinger D. , Shaw S. , Weidmann P. Plasma kinetics of synthetic alpha-human atrial natriuretic peptide in man. Miner Electrol Metab 1986; 12: 371–4.

Yandle T. , Richards A. , Nicholls M. , Cuneo R. , Espiner E. , Livesey J. Metabolic clearance rate and plasma half-life of alpha-human atrial natriuretic peptide in man. Life Sci 1986; 38: 1827–33.

Nakajima S. , Suzuki H. , Kageyama Y. , Takita T. , Saruta T. Hormonal responses to synthetic atrial peptide in patients on regular hemodialysis. Acta Endocrinol 1988; 119: 257–62.